(Q40991729)

25 September 2017

1 reference

title

Nitric oxide and nitrovasodilators: similarities, differences, and interactions (English)

1 reference

25 September 2017

Kelly RA

1

1 reference

25 September 2017

Smith TW

series ordinal

2

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 May 1996

1 reference

American Journal of Cardiology

25 September 2017

published in

1 reference

25 September 2017

volume

77

1 reference

25 September 2017

issue

13

1 reference

25 September 2017

page(s)

2C-7C

1 reference

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Redox signaling: nitrosylation and related target interactions of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

The nitrovasodilators. New ideas about old drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Nitric oxide synthases: Roles, tolls, and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Nitroprusside and regional vascular capacitance in patients with severe congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Right ventricular-vascular interaction in congestive heart failure. Importance of low-frequency impedance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Predictors of pressure and stroke volume response to afterload reduction with nitroprusside in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Phenomenon of nitrate tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Nitrates in congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Effects of diuretic therapy on the development of tolerance during continuous therapy with nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Prevention of nitrate tolerance with angiotension converting enzyme inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Captopril potentiates the effects of nitroglycerin in the coronary vascular bed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Enhancement of the efficacy of isosorbide dinitrate by captopril in stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Effect of therapy with an angiotensin-converting enzyme inhibitor on hemodynamic and counterregulatory responses during continuous therapy with nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Possible involvement of S-nitrosothiols in the activation of guanylate cyclase by nitroso compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Mechanisms of interaction between the sulfhydryl precursor L-methionine and glyceryl trinitrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Nitrate tolerance: the lack of effect of N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Different susceptibility to the development of nitroglycerin tolerance in the arterial and venous circulation in humans. Effects of N-acetylcysteine administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Nitrate tolerance in epicardial arteries or in the venous system is not reversed by N-acetylcysteine in vivo, but tolerance-independent interactions exist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Haemodynamic effects of glyceryl trinitrate during continuous 24 hour infusion in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Potentiation of isosorbide dinitrate effects with N-acetylcysteine in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Preventive administration of intravenous N-acetylcysteine and development of tolerance to isosorbide dinitrate in patients with angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Nitric oxide in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

An obligatory role for nitric oxide in autonomic control of mammalian heart rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Transforming growth factor β2 inhibits interleukin 1β- and tumour necrosis factor α-induction of nitric oxide synthase in rat renal mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1 alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Immune cytokines and cardiac disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Nitric Oxide Potently and Reversibly Deenergizes Mitochondria at Low Oxygen Tension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900182-8

10.1016/S0002-9149(96)00182-8

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference